Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate.

about

Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus.Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea.

P2860

Q48324081-911C74AE-F518-4999-BBC0-5A57BD2A99E7 Q50201468-5003667F-51F8-477A-A558-02E6AD30DCEF

P2860

Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate.

Item

http://www.wikidata.org/entity/Q38600057

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Neuroendocrine tumor G3: a pan ...... ith a high proliferative rate.

@en

type

Item

label

Neuroendocrine tumor G3: a pan ...... ith a high proliferative rate.

@en

prefLabel

Neuroendocrine tumor G3: a pan ...... ith a high proliferative rate.

@en

P1476

Neuroendocrine tumor G3: a pan ...... ith a high proliferative rate.

@en

P2093

Hiroaki Kumazawa

http://www.w3.org/2001/XMLSchema#string

Hiroki Tanaka

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kaneko

http://www.w3.org/2001/XMLSchema#string

Hiroshi Okano

http://www.w3.org/2001/XMLSchema#string

Katsumi Mukai

http://www.w3.org/2001/XMLSchema#string

Shimpei Matsusaki

http://www.w3.org/2001/XMLSchema#string

Tomohiro Sase

http://www.w3.org/2001/XMLSchema#string

Tomonori Saito

http://www.w3.org/2001/XMLSchema#string

Yoshiaki Isono

http://www.w3.org/2001/XMLSchema#string

Youichirou Baba

http://www.w3.org/2001/XMLSchema#string

P2860

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.

The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.

Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.

Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.

The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.

P2888

s12328-015-0609-4

P304

414-420

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12328-015-0609-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030599742

http://www.w3.org/2001/XMLSchema#string

P698

26439620

http://www.w3.org/2001/XMLSchema#string

Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate.

about

P2860

P2860

Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698